GlycoBiomarker Leading Innovation Co. Ltd.


February 1, 2018
Receipt of the 100th (2017) New Technology Development Grant
February 1, 2018
GL-i and PSS start joint research aiming automation of multiple assay for glycobiomarker measurement
December 11, 2017
Proposal by our group leader Shimazaki (Glycodiagnostics R&D Group) was selected for the grant by the Hirosawa Foundation for Technology
April 27, 2017
GL-i was introduced in Nikkei BioTech Online
April 16, 2017
Our fellow Dr. Narimatsu participates in the Database Integration Coordination Program of the National Bioscience Database Center of Japan Science and Technology Agency (JST)
April 1, 2017
Our CTO Dr. Kuno participates in the International Collaborative Research Program (e-Asia) of the Japan Agency for Medical Research and Development (AMED).
March 31, 2017
GL-i was introduced in the AIST website "TECH Meets BUSINESS"
December 22, 2016
Introduction of GL-i as a News story in The Nikkan Kogyo Shimbun (Business & Technology Daily News)
September 1, 2016
Our CTO, Dr. Kuno participates in the Development of Advanced Measurement and Analysis Systems Program of the Japan Agency for Medical Research and Development (AMED)
August 26, 2016
Our CTO, Dr. Atsushi Kuno (AIST Chief senior researcher, Biotechnology Research Institute for Drug Discovery [BRD]), AIST Principal research manager of BRD Dr. Hisashi Narimatsu, and Manager of Sysmex Co., Dr. Yoichi Takahama received the 14th Minister of Economy, Trade and Industry Award
July 4, 2016
GL-i and Sysmex pursuing joint development to provide new diagnostic reagents employing glycosylation markers
June 30, 2016
GL-i was selected for “2016 Project for promoting bridging research for small- and medium-sized companies” by New Energy and Industrial Technology Development Organization (NEDO)

Page Top